Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches
M. Tahir ul Qamar, A. Rehman, U. A. Ashfaq, M. Q. Awan, I. Fatima, F. Shahid, L.-L. Chen
This paper designs a multiepitope vaccine against SARS-COV-2 using immunoinformatics and in silico methods, showing it is non-allergenic, antigenic, and binds strongly to TLR3 and TLR8.
bioRxiv · Feb 28, 2020Immunology